Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Degludec vs Glargine U100 for T1D Travel
NCT03668808Phase 4Completed
- Sponsor
- Sansum Diabetes Research Institute
- Start
- Nov 2018
- Primary completion
- Sep 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin degludec in type 1 diabetes mellitus (T1D), sponsored by Sansum Diabetes Research Institute. Started Nov 2018; status: completed.
02
Drugs
insulin degludec
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03668808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03668808.